Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT03606473

Brain Mechanisms in Young Adults (MHP)

Exploration of Mechanisms of Effects of Prenatal Cocaine Exposure in Young Adults

Sponsor: Gale Richardson

Updated 6 times since 2018 Last updated: Sep 2, 2020 Started: Jan 24, 2018 Primary completion: Aug 31, 2020 Completion: Aug 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03606473, this EARLY_PHASE1 trial focuses on Cocaine-Related Disorders and remains completed. Sponsored by Gale Richardson, it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Oct 2020 — Jan 2021 [monthly]

Completed EARLY_PHASE1

Status: Recruiting → Completed
Aug 2019 — Oct 2020 [monthly]

Recruiting EARLY_PHASE1

▶ Show 1 earlier version

Aug 2018 — Aug 2019 [monthly]

Recruiting EARLY_PHASE1

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gale Richardson
National Institute on Drug Abuse (NIDA)

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States